Nano-X Imaging (NNOX) Projected to Announce Quarterly Earnings on Monday

Nano-X Imaging (NASDAQ:NNOX) is anticipated to post its Q1 2026 results before the market opens on Monday, July 20th. Analysts expect Nano-X Imaging to post earnings of ($0.20) per share and revenue of $4.5380 million for the quarter. Individuals can check the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, June 25, 2026 at 8:30 AM ET.

Nano-X Imaging (NASDAQ:NNOX) last issued its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) earnings per share (EPS) for the quarter. The business had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Stock Performance

NASDAQ NNOX opened at $1.12 on Friday. The firm’s fifty day moving average is $1.57 and its two-hundred day moving average is $2.18. Nano-X Imaging has a one year low of $0.73 and a one year high of $5.69. The firm has a market cap of $77.94 million, a PE ratio of -0.71 and a beta of 1.24.

Institutional Trading of Nano-X Imaging

A number of institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Nano-X Imaging by 8.4% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company’s stock worth $182,000 after acquiring an additional 2,724 shares during the period. The Manufacturers Life Insurance Company raised its holdings in Nano-X Imaging by 20.5% during the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock worth $116,000 after purchasing an additional 3,818 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Nano-X Imaging by 62.1% during the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after purchasing an additional 5,283 shares in the last quarter. BNP Paribas Financial Markets boosted its position in Nano-X Imaging by 64.6% during the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock worth $73,000 after purchasing an additional 7,749 shares in the last quarter. Finally, Mariner LLC grew its holdings in Nano-X Imaging by 70.5% in the fourth quarter. Mariner LLC now owns 20,825 shares of the company’s stock valued at $58,000 after purchasing an additional 8,614 shares during the last quarter. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on NNOX shares. Alliance Global Partners downgraded Nano-X Imaging from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $5.00 to $3.00 in a report on Tuesday, July 7th. D. Boral Capital restated a “buy” rating and issued a $5.00 target price on shares of Nano-X Imaging in a research note on Monday, April 20th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a report on Wednesday, July 8th. Finally, Zacks Research upgraded shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $4.00.

About Nano-X Imaging

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.